NCT01980524View on ClinicalTrials.gov

The Impact of Free Fatty Acid (FFA-) Suppression on Myocardial Lipids and Function in Patients With Type 2 Diabetes

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

December 31, 2015

Study Completion Date

May 31, 2016

Conditions
Type 2 Diabetes
Interventions
DRUG

acipimox

DRUG

Placebo Oral Capsule

Trial Locations (1)

1090

Division of Endocrinology and Metabolism, Internal Medicine III, Medical University of Vienna, Vienna

All Listed Sponsors
lead

Medical University of Vienna

OTHER

NCT01980524 - The Impact of Free Fatty Acid (FFA-) Suppression on Myocardial Lipids and Function in Patients With Type 2 Diabetes | Biotech Hunter | Biotech Hunter